Browsing: Duchenne

Conditions

Becker and Duchenne muscular dystrophies

By 0

Suresnes, France, July 13, 2026– Servier, an independent international pharmaceutical group governed by a foundation, today announced that it has completed the acquisition of the muscular dystrophy business of Edgewise Therapeutics Inc. (Nasdaq: EWTX), for up to $2.65 billion, including upfront payment of $1.55 billion as well as up to $1.1 billion in regulatory and…